Billions of dollars of profit are at stake. The new generation of biotech drugs is upon us. Will they help or will they kill? The answer, it appears, depends on the dose. More importantly, the answer depends on the moral integrity of oncologists that treat their patients. What should society do with doctors that put money in their pockets as a priority over the lives of their patients?
Read More: anemia,
biotech drugs,
cancer treatment,
ESAs,
FDA,
oncologist,
profit,
transfusions
Mainstream media is buzzing with the announcement that Johnson and Johnson will invest millions to help bring a new blood test to market that can readily identify even a single cancer cell in the blood stream. While the technology has been under development for the past five years it will still take several more years to bring it to market. It may be one of the great diagnostic advances of all time.
Read More: cancer treatment,
clinical research
It is in the best interests of any person going through cancer treatment to utilize various nutrients that can help the cancer treatment work better. Researchers at the Indiana University School of Medicine reviewed the science on DHA and cancer and came to the following conclusion, “Use of DHA with anticancer treatments provides an avenue to therapeutic improvement that involves less risk or side effects for patients and reduced regulatory burden for implementation.”
Read More: cancer,
cancer treatment,
DHA